Cardinal Health Inc.

CAH ·Healthcare, Medical Distribution, United States

Income Statement

Line Item	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue	$254.25B	$222.58B	$224.26B	$205.01B	$181.36B	$162.47B	$152.90B	$145.53B
Pharmaceutical	—	—	$212.32B	$193.03B	$170.15B	$150.79B	$137.46B	$129.91B
Medical	—	—	$11.96B	$11.99B	$11.22B	$11.69B	$15.45B	$15.63B
Eliminations	—	—	$-20.0M	$-5.0M	$-4.0M	$-12.0M	$-4.0M	$-6.0M
Cost of Revenue	$244.47B	$214.41B	$219.41B	$198.11B	$174.84B	$155.69B	$146.05B	$138.70B
Gross Profit	$9.77B	$8.17B	$7.41B	$6.87B	$6.48B	$6.78B	$6.87B	$6.83B
Gross Margin	3.8%	3.7%	3.3%	3.4%	3.6%	4.2%	4.5%	4.7%
Operating Expenses
Research & Development	—	—	—	—	—	—	—	—
SG&A Expense	$6.13B	$5.38B	$5.00B	$4.80B	$4.51B	$4.53B	$4.57B	$4.48B
Operating Income	$2.61B	$2.28B	$1.24B	$752.0M	$-607.0M	$472.0M	$-4.10B	$2.06B
Operating Margin	1.0%	1.0%	0.6%	0.4%	-0.3%	0.3%	-2.7%	1.4%
Interest Expense	$348.0M	$215.0M	$51.0M	$84.0M	$147.0M	$180.0M	$238.0M	$294.0M
Pretax Income	$2.17B	$2.10B	$1.20B	$663.0M	$-784.0M	$323.0M	$-3.77B	$1.75B
Income Tax Expense	$469.0M	$532.0M	$348.0M	$332.0M	$153.0M	$-289.0M	$-79.0M	$386.0M
Net Income	$1.71B	$1.56B	$852.0M	$330.0M	$-938.0M	$611.0M	$-3.70B	$1.36B
Net Margin	0.7%	0.7%	0.4%	0.2%	-0.5%	0.4%	-2.4%	0.9%
EPS (Basic)	$7.27	$6.48	$3.48	$1.27	$-3.37	$2.09	$-12.61	$4.55
EPS (Diluted)	$7.23	$6.45	$3.45	$1.26	$-3.37	$2.08	$-12.61	$4.53
Shares Outstanding (Basic)	236.0M	241.0M	245.0M	261.0M	279.0M	292.0M	293.0M	300.0M
Shares Outstanding (Diluted)	237.0M	242.0M	247.0M	262.0M	279.0M	294.0M	293.0M	301.0M
Dividends Per Share	$2.04	$2.02	$2.00	$1.98	$1.96	$1.94	$1.92	$1.91

← Newer Page 1 of 3 Older →